In addition, genetic targeting of Camkk2 in immune-intact mouse models of obesity-driven prostate cancer demonstrated simultaneous anti-cancer efficacy and improvements in whole-body metabolic homeostasis that we propose may be linked via a novel tumor-extrinsic, CAMKK2-mediated mechanism of action. Here, CAMKK2 is linked to obesity due to melanocortin 4 receptor deficiency.